Results tagged “nanotechnology” from Innovations

IBM Looks Ahead to Even Smaller Transistors

September 21, 2008 12:00 PM | Permalink | Comments (0)

Computer chips have become more powerful by cramming more and smaller transistors into the same space, and the industry right now is moving from technology where the key size measurement is 65 nanometers to 45-nanometer technology. But as CNET News reports, IBM is looking a couple technology generations ahead, to 22-nanometer devices. The challenge they're tackling: Technology to produce such small features doesn't yet exist, and it's not obvious how to create it.

Web pick posted by Neil Savage, Xconomy.com

Tags: CNET News, IBM, nanotechnology, transistors

Government Considers X Prizes for Nanotech

July 21, 2008 7:00 AM | Permalink | Comments (0)

Big prizes for technological innovation are becoming all the rage in Washington. Ars Technica tells us that Republican Senator Olympia Snowe of Maine and Democratic Senator Ron Wyden of Oregon have introduced a bill to fund prizes for advancements in nanotechnology. They're hoping the fund will attract money from private investors as well.

Nanotechnology is a bit of a catch-all phrase for the study of materials that can be manufactured in bulk on the extremely tiny nanometer scale. The field as such didn't exist until recent years, when the technology for creating materials at this fine scale became more widespread.

Web pick posted by Neil Savage, Xconomy.com

Tags: Ars Technica, nanotechnology, Olympia Snowe, Ron Wyden

Cancer Nanotech a "Good Example" of Government Spending

July 9, 2008 6:00 AM | Permalink | Comments (0)

The development of nanotechnology as a tool to fight cancer is leading to promising treatments, showing that government spending in a focused area of research can be good for business and for the public, argues a writer at Wired. Looking at the field of nanotechnology developed to treat cancer, the author says funding from the National Cancer Institute has led to promising developments in the field. So far, there are at least 48 clinical trials going on, many of them in Phase II, the intermediate phase in testing new medicines.

Web pick posted by Neil Savage, Xconomy.com

Tags: nanotechnology, National Cancer Institute, Wired